Chronic Matrix Metalloproteinase Inhibition Following Myocardial Infarction in Mice: Differential Effects on Short and Long-Term Survival-Reference-Cited by-同舟云学术

Chronic Matrix Metalloproteinase Inhibition Following Myocardial Infarction in Mice: Differential Effects on Short and Long-Term Survival

Published:2006-06-06 Issue:3 Volume:318 Page:966-973
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Spinale Francis G.,Escobar G. Patricia,Hendrick Jennifer W.,Clark Leslie L.,Camens Sarah S.,Mingoia Joseph P.,Squires Christina G.,Stroud Robert E.,Ikonomidis John S.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference37 articles.

1. Release of matrix metalloproteinases following alcohol septal ablation in hypertrophic obstructive cardiomyopathy

2. Matrix metalloproteinases: a tail of a frog that became a prince

3. Gender differences in cardiac function during early remodeling after acute myocardial infarction in mice

4. Matrix metalloproteinase abundance in human myocardial fibroblasts: effects of sustained pharmacologic matrix metalloproteinase inhibition

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recovery of left ventricular function following in vivo reexpression of cardiac myosin binding protein C;Journal of General Physiology;2018-12-20

2. Tollip Negatively Regulates Vascular Smooth Muscle Cell–Mediated Neointima Formation by Suppressing Akt‐Dependent Signaling;Journal of the American Heart Association;2018-06-19

3. Guidelines for measuring cardiac physiology in mice;American Journal of Physiology-Heart and Circulatory Physiology;2018-04-01

4. Early changes of left ventricular filling pattern after reperfused ST-elevation myocardial infarction and doxycycline therapy: Insights from the TIPTOP trial;International Journal of Cardiology;2017-08

5. Pharmacological reasons that may explain why randomized clinical trials have failed in acute heart failure syndromes;International Journal of Cardiology;2017-04